Japan Viscosupplementation Market Size & Outlook, 2025-2033

The viscosupplementation market in Japan is expected to reach a projected revenue of US$ 2,585.7 million by 2033. A compound annual growth rate of 6.1% is expected of Japan viscosupplementation market from 2025 to 2033.
Revenue, 2024 (US$M)
$1,481.4
Forecast, 2033 (US$M)
$2,585.7
CAGR, 2025 - 2033
6.1%
Report Coverage
Japan

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Japan viscosupplementation market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Japan viscosupplementation market highlights

  • The Japan viscosupplementation market generated a revenue of USD 1,481.4 million in 2024 and is expected to reach USD 2,585.7 million by 2033.
  • The Japan market is expected to grow at a CAGR of 6.1% from 2025 to 2033.
  • In terms of segment, single injection was the largest revenue generating product in 2024.
  • Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.


Viscosupplementation market data book summary

Market revenue in 2024USD 1,481.4 million
Market revenue in 2033USD 2,585.7 million
Growth rate6.1% (CAGR from 2025 to 2033)
Largest segmentSingle injection
Fastest growing segmentSingle Injection
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationSingle Injection, Three Injection, Five Injection
Key market players worldwideDePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG


Other key industry trends

  • In terms of revenue, Japan accounted for 28.0% of the global viscosupplementation market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, Japan viscosupplementation market is projected to lead the regional market in terms of revenue in 2033.
  • Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 117.3 million by 2033.

Single injection was the largest segment with a revenue share of 47.54% in 2024. Horizon Databook has segmented the Japan viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2021 to 2033.


According to International Osteoporosis Foundation, in 2013, around 10% of the Japan’s population aged over 40 were diagnosed with osteoporosis, with 3 million cases in men and 9.8 million in women. The Japanese have high awareness about osteoporosis and in alignment with which a separate fracture registry has been established, where hip fracture data is derived every 5 years.

The Ministry of Health mandates osteoporosis screening for population along with established programs and exercises. Major industry players, such as Seikagaku Corporation, are located in the country and contribute to address the rising demand for hyaluronic acid injections.

In November 2016, the company signed an agreement with Zimmer Biomet to capture a share of the growing market in the U.S. The company manufacturers VISCO-3, which was approved by FDA in December 2015. The deal also included distribution of the company’s single-injection Gel-One and SUPARTZ-FX five-injection products.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Viscosupplementation Market Companies

Name Profile # Employees HQ Website
Lifecore Biomedical Inc View profile 459 3515 Lyman Boulevard, Chaska, MN, United States, 55318 https://www.lifecore.com
Ferring View profile 5001-10000 Saint-prex, Vaud, Switzerland, Europe https://www.ferring.com
Anika Therapeutics Inc View profile 357 32 Wiggins Avenue, Bedford, MA, United States, 01730 https://www.anika.com
LG Chem View profile 10001+ Seoul, Seoul-t'ukpyolsi, South Korea, Asia https://www.lgchem.com
Smith & Nephew PLC View profile 18452 Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE https://www.smith-nephew.com
DePuy Synthes View profile 5001-10000 Raynham, Massachusetts, United States, North America https://depuysynthes.com
Zimmer Biomet Holdings Inc View profile 18000 345 East Main Street, Warsaw, IN, United States, 46580 https://www.zimmerbiomet.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com

Japan viscosupplementation market size, by product, 2021-2033 (US$M)

Japan Viscosupplementation Market Outlook Share, 2024 & 2033 (US$M)

Japan viscosupplementation market size, by product, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online